Linda C. Sandin

Enhanced Tumor Eradication by Combining CTLA-4 or PD-1 Blockade With CpG Therapy

Sara M. Mangsbo, Linda C. Sandin, Kerstin Anger et al. · Journal of Immunotherapy · 2010 · 191 citations

Pd-1 Blockade, Immunology, Immunodominance +18

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Molly A. Taylor, Adina Hughes, Josephine Walton et al. · Journal for ImmunoTherapy of Cancer · 2019 · 98 citations · Full text

Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer

Linda C. Sandin, Anna Orlova, Erika Gustafsson et al. · Cancer Immunology Research · 2013 · 97 citations · Full text

Immunology, Pathology, Antigen Processing +17

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo

Linda C. Sandin, Fredrik Eriksson, Peter Ellmark et al. · OncoImmunology · 2014 · 85 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +23

Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)

Richard A. Ward, Mark J. Anderton, Paul A. Bethel et al. · Journal of Medicinal Chemistry · 2019 · 75 citations · Full text